Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy, Journal Year: 2024, Volume and Issue: 327, P. 125387 - 125387
Published: Nov. 3, 2024
Language: Английский
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy, Journal Year: 2024, Volume and Issue: 327, P. 125387 - 125387
Published: Nov. 3, 2024
Language: Английский
Journal of Fungi, Journal Year: 2023, Volume and Issue: 9(3), P. 355 - 355
Published: March 15, 2023
Commonly found colonizing the human microbiota, Candida albicans is a microorganism known for its ability to cause infections, mainly in vulvovaginal region, and responsible 85% 90% of candidiasis (VVC) cases. The development drug resistance C. isolates after long-term therapy with fluconazole an important complication solve new therapeutic strategies are required target this organism pathogenicity. In present study, phenyllactic acid (PLA) broad-spectrum antimicrobial compound was investigated antifungal antivirulence activities against clinical albicans. Previously characterized strains from women VVC ATCC90028 were used evaluate time dependent killing assay activity PLA showing MIC 7.5 mg mL-1 complete reduction viable cells detected by kinetics 4 h treatment PLA. Additionally, significantly reduced biomass metabolic biofilms impaired biofilm formation also changes ERG11, ALS3, HWP1 genes expression as qPCR. eradicated pre-formed showed confocal laser scanning microscopy (CLSM) observations. Furthermore, prolonged survival rate Galleria mellonella infected isolates. These results indicate that promising candidate novel safe agents candidiasis.
Language: Английский
Citations
17Plants, Journal Year: 2023, Volume and Issue: 12(2), P. 358 - 358
Published: Jan. 12, 2023
Candida auris represents an emerging pathogen that results in nosocomial infections and is considered a serious global health problem. The aim of this work was to evaluate the vitro antifungal efficacy Cinnamomum cassia essential oil (CC-EO) pure or formulated polycaprolactone (PCL) nanoparticles against ten clinical strains C. auris.nanoparticles PCL were produced using CC-EO (nano-CC-EO) cinnamaldehyde (CIN) through nanoprecipitation method. chemical profile both nano-CC-EO evaluated SPME sampling followed by GC-MS analysis. Micro-broth dilution tests performed fungistatic fungicidal effectiveness CIN, nano-formulated. Furthermore, checkerboard synergistic action with micafungin fluconazole conducted. Finally, biofilm disrupting activity formulations evaluated.GC-MS analysis shows different composition between nano-CC-EO. Moreover, microbiological analyses do not show any variation either towards planktonic form (MICCC-EO = 0.01 ± MICnano-CC-EO 0.02 0.01) form. No drugs tested found.both same antimicrobial are potential assets fight auris.
Language: Английский
Citations
14Antibiotics, Journal Year: 2022, Volume and Issue: 11(12), P. 1743 - 1743
Published: Dec. 2, 2022
Infectious diseases caused by various nosocomial microorganisms affect worldwide both immunocompromised and relatively healthy persons. Bacteria fungi have different tools to evade antimicrobials, such as hydrolysis damaging the drug, efflux systems, formation of biofilm that significantly complicates treatment infection. Here, we show myrtenol potentiates antimicrobial biofilm-preventing activity conventional drugs against S. aureus C. albicans mono- dual-species cultures. In our study, two optical isomers, (−)-myrtenol (+)-myrtenol, been tested either antibacterials, antifungals, or enhancers drugs. (+)-Myrtenol demonstrated a synergistic effect with amikacin, fluconazole, benzalkonium chloride on 64–81% clinical isolates albicans, including MRSA fluconazole-resistant fungi, while increased properties amikacin fluconazole repress in half isolates. Furthermore, was able potentiate up sixteen-fold planktonic cells an aureus–C. mixed culture repressed adhesion aureus. The mechanism (+)-myrtenol synergy apparently driven membrane damage since terpenes led significant drop potential similar action chloride. Thus, due low toxicity myrtenol, it seems be promising agent increase efficiency infections bacteria genus Candida well fungal–bacterial infections, resistant strains.
Language: Английский
Citations
19Antibiotics, Journal Year: 2024, Volume and Issue: 13(1), P. 80 - 80
Published: Jan. 15, 2024
The opportunistic human fungal pathogen Candida albicans produces and releases into the surrounding medium extracellular vesicles (EVs), which are involved in some processes as communication between cells host–pathogen interactions during infection. Here, we have conducted isolation of EVs produced by a clinical isolate C. biofilm formation proved their effect towards ability Gram-negative bacterial Klebsiella pneumoniae to adhere HaCaT form vitro. results represent first evidence an antagonistic action against bacteria.
Language: Английский
Citations
4Journal of Fungi, Journal Year: 2024, Volume and Issue: 10(6), P. 424 - 424
Published: June 16, 2024
Two new polyketide derivatives, penirubenones A and B (1 2), two naturally rare amino-bis-tetrahydrofuran penirubenamides (3 4), together with nine known compounds (5–13) were isolated from the marine-derived fungus Penicillium rubens BTBU20213035. The structures identified by HRESIMS 1D 2D NMR analyses, their absolute configurations determined a comparison of experimental calculated electronic circular dichroism (ECD) spectroscopy 13C data. We found that 6 exhibited antibacterial activity against Staphylococcus aureus, an MIC value 3.125 μg/mL, 1 2 showed synergistic antifungal Candida albicans at 12.5 50 μg/mL 0.0625 rapamycin.
Language: Английский
Citations
4Microbial Pathogenesis, Journal Year: 2025, Volume and Issue: 199, P. 107280 - 107280
Published: Jan. 5, 2025
Language: Английский
Citations
0Applied Food Research, Journal Year: 2025, Volume and Issue: unknown, P. 100905 - 100905
Published: April 1, 2025
Language: Английский
Citations
0Published: Jan. 1, 2025
Language: Английский
Citations
0Pharmaceutics, Journal Year: 2024, Volume and Issue: 16(7), P. 957 - 957
Published: July 19, 2024
Recently, a large number of nosocomial infections have been caused by an emerging pathogen that is rising as worldwide issue in human health:
Language: Английский
Citations
3Molecules, Journal Year: 2025, Volume and Issue: 30(8), P. 1738 - 1738
Published: April 13, 2025
Nowadays, the spread of foodborne diseases and growing concerns about antibiotic resistance have shifted focus researchers towards use substances natural origin. Phenyllactic acid (PLA), a naturally produced compound, has already demonstrated antimicrobial properties against pathogenic microorganisms those responsible for food spoilage. This study examines antibacterial antibiofilm PLA pathogens such as Salmonella enterica Derby Escherichia coli O26. The showed that effectively inhibited both biofilm formation bacterial planktonic growth, with minimal inhibitory concentrations (MICs) ranging from 2 to 2.75 mg mL−1. A dose-dependent inhibition was observed, reaching approximately 90% strains 50% E. at 1.5 cytotoxicity evaluation on Caco-2 cells well-tolerated up PLA’s effectiveness also in real matrices, where its application minced beef stored 4 °C significantly reduced microbial populations, unlike untreated samples counts increased. good ability inhibit eradicate mature biofilm, measuring total biomass. Additionally, found be biocompatible cells, confirming it poses no health risk tested concentrations. observed adhesion intestinal suggesting potential preventing colonization. These results highlight promising agent preservation, applications sustainable packaging controlling contamination processing. Future studies should further explore long-term stability interactions complex environments.
Language: Английский
Citations
0